Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tarek M. Okda"'
Autor:
Ahmed N. Elkattan, Sayad El-saadany, Mohamed Azzazy, Tarek M. Okda, Maha Mamdouh, Osama Ahmed, Ali H. El-Far, Manar ElKhayat, Ghadeer M. Albadrani, Muath Q. Al-Ghadi, Mohamed M. Abdel-Daim, Hala El Daous
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31623- (2024)
This study sheds the light on the potential of licorice (Glycyrrhiza glabra) root aqueous extract as a cornerstone for mitigating and detoxifying the residues of the widely used agricultural Glyphosate-based pesticides (GBPs). This study examined the
Externí odkaz:
https://doaj.org/article/1d2fdaab63d2434b847f8fc693a1cc4e
Autor:
Kholoud A. Elzanaty, Gamal A. Omran, Ehab Kotb Elmahallawy, Ashraf Albrakati, Ayman A. Saleh, Naief Dahran, Alaa S. Alhegaili, Ahmad Salahuddin, Heba Abd-El-Azim, Ahmed Noreldin, Tarek M. Okda
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 937 (2024)
There is a growing interest in discovering natural sources of anti-cancer drugs. Sesamol (SES) is a phenolic compound with antitumor effects. The present study aimed to investigate the anticancer properties of SES and its nano-suspensions (SES-NS) co
Externí odkaz:
https://doaj.org/article/403a0b5a73d54a05948f5ba4cc70904d
Publikováno v:
Contemporary Oncology, Vol 26, Iss 3, Pp 229-238 (2022)
Externí odkaz:
https://doaj.org/article/cb175103b4b64e33bf0fb7b241899a4a
Publikováno v:
Contemporary Oncology, Vol 25, Iss 2, Pp 118-124 (2021)
Externí odkaz:
https://doaj.org/article/cc7c0468e4b2465cbc66f45e49527664
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 146, Iss , Pp 112599- (2022)
Despite considerable advances in cancer treatment, chemotherapy remains a cornerstone in breast cancer therapy. Therefore, reducing chemoresistance and adverse effects of chemotherapy is a priority. In this regard, Baicalin (BA) is the dominant natur
Externí odkaz:
https://doaj.org/article/17fc107243834d8c80b46d07948ddd8d
Autor:
Mohamed Fayez Dekinash, Tarek M. Okda, Ehab Kotb Elmahallawy, Fathy Kandil El-Fiky, Gamal Abd El Hay Omran, Emil Svajdlenka, Naief Dahran, Manal F. El-Khadragy, Wafa A. Al-Megrin, El Moataz Bellah Ali El Naggar
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1406 (2022)
Plants from the genus Astragalus are gaining attention for their pharmacological importance. However, the information available regarding the HPLC–MS/MS chemical profile of A. fruticosus is inadequate. In this study, we performed HPLC–MS/MS analy
Externí odkaz:
https://doaj.org/article/a6f19a231e9342609f1636563e69d34c
Autor:
Tarek M. Okda, Gamal M. K. Atwa, Ahmed Fathy Eldehn, Naief Dahran, Khalaf F Alsharif, Ehab Kotb Elmahallawy
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 352 (2022)
Thyroid cancer is among the most prevalent cancers with different types and stages. New markers are required for the prognosis and diagnosis of the disease. The present study aimed to detect the role of new markers, including galectin-3 (Gal-3) and t
Externí odkaz:
https://doaj.org/article/f9d90956c9cc479a93a979950d0feecc
Autor:
Hashem O. Zahra, Gamal A. Omran, Ahmed G. Gewely, Ahmed Fathy Eldehn, Walied Abdo, Ehab Kotb Elmahallawy, Tarek M. Okda
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2080 (2021)
Well-differentiated thyroid cancer (WDTC) is a malignant head and neck tumor with a very high incidence. Thyroidectomized WDTC patients have been referred to nuclear medicine for radioactive iodine (RAI) ablation therapy and/or annual follow-up with
Externí odkaz:
https://doaj.org/article/2c6908eea1034a4d8a0be85031e35b85
Autor:
Mahmoud M. A. Elsayed, Tarek M. Okda, Gamal M. K. Atwa, Gamal A. Omran, Atef E. Abd Elbaky, Abd El hakim Ramadan
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 648 (2021)
Luteolin (LUT) is a natural flavonoid with low oral bioavailability with restricted clinical applications due to its low solubility. LUT shows significant anti-tumor activity in many cancer cells, including hepatocellular carcinoma (HCC). The most re
Externí odkaz:
https://doaj.org/article/1c2a726a5367469da032672fa0d79543